BioCorRx (BICX) Notes Payables (2016 - 2025)
Historic Notes Payables for BioCorRx (BICX) over the last 17 years, with Q3 2025 value amounting to $1.5 million.
- BioCorRx's Notes Payables rose 2014.79% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 2014.79%. This contributed to the annual value of $1.3 million for FY2024, which is 12138.9% up from last year.
- According to the latest figures from Q3 2025, BioCorRx's Notes Payables is $1.5 million, which was up 2014.79% from $1.5 million recorded in Q2 2025.
- In the past 5 years, BioCorRx's Notes Payables registered a high of $1.5 million during Q3 2025, and its lowest value of $21480.0 during Q1 2021.
- For the 5-year period, BioCorRx's Notes Payables averaged around $799991.2, with its median value being $790110.0 (2021).
- Data for BioCorRx's Notes Payables shows a peak YoY increase of 357835.2% (in 2022) and a maximum YoY decrease of 6233.41% (in 2022) over the last 5 years.
- BioCorRx's Notes Payables (Quarter) stood at $790110.0 in 2021, then plummeted by 62.33% to $297602.0 in 2022, then soared by 103.88% to $606750.0 in 2023, then soared by 121.39% to $1.3 million in 2024, then rose by 15.23% to $1.5 million in 2025.
- Its Notes Payables was $1.5 million in Q3 2025, compared to $1.5 million in Q2 2025 and $1.5 million in Q1 2025.